A rich new Credit Suisse report, “Global Biotechnology – An Outlook for 2015,” was flush with cool data about trends in the biotech industry. The analysis lists out 10 key themes for 2015. Here’s the highlight reel:
For the past four years, biotech outperformed the S&P500 – indeed, it has been the leading sector and notably, it doesn’t think the IPO and financing window’s going to close anytime soon. CS projects that biotech can still outperform the general market, even if it doesn’t retain the number one position – in part because of the “fundamental shift in large cap biotech’s business model” that’s going on right now.
Image: http://medcitynews.com
